U.S. Anti-Doping Agency (USADA)
Click here to log in to the
Athlete Connect application
Click here to view your
test history and results
Search Medications & Ingredients
U.S. track & field athlete, Andrew Carnes, of Northfield, Ohio, has accepted a two-year period of ineligibility for a non-analytical anti-doping rule violation.
IGF-1 can enhance the production of lean muscle as well as aid in recovery time, but when used without medical necessity, exogenous IGF-1 can cause serious harm.
Members of USADA’s staff donated 56 man-hours to the Colorado Springs community volunteering with Pikes Peak Habitat for Humanity on March 13, 2014.
We have seen an increase in inquires at USADA about the use of Intravenous (IV) Infusions for this purpose, and would like to assist athletes and medical personnel by clarifying this.
Autologous blood transfusion is the collection and re-infusion of the patient’s own blood or blood components.
USADA’s Olympic Education team is devoted to educating Team USA providing extensive anti-doping education to thousands of athletes each year.
The Japan Anti-Doping Agency (JADA) invited representatives from the United States Anti-Doping Agency (USADA) to meet, in order to share experience and best practices and to further our joint cooperative efforts.
USADA must collect a minimum of 90mL during a urine test to ensure that all drug tests can be performed.
Statement From USADA CEO Travis T. Tygart On The Designer Anabolic Steroid Control Act Introduced Today By Senators Hatch And Whitehouse
